TransMedics Group (TMDX)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of TransMedics Group (TMDX)
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Key Insights
Critical company metrics and information
Share Price
$71.72Market Cap
$2.41 BillionTotal Outstanding Shares
33.56 Million SharesTotal Employees
584Dividend
No dividendIPO Date
May 2, 2019SIC Description
Electromedical & Electrotherapeutic ApparatusHomepage
https://www.transmedics.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Operating Activities | $6.86 Million |
Net Cash Flow From Investing Activities | $-47.76 Million |
Net Cash Flow From Financing Activities | $7.86 Million |
Net Cash Flow, Continuing | $-33.04 Million |
Exchange Gains/Losses | $386000.00 |
Net Cash Flow | $-32.66 Million |
Net Cash Flow From Financing Activities, Continuing | $7.86 Million |
Net Cash Flow From Investing Activities, Continuing | $-47.76 Million |
Net Cash Flow From Operating Activities, Continuing | $6.86 Million |
Income Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Revenues | $108.76 Million |
Nonoperating Income/Loss | $322000.00 |
Cost Of Revenue | $47.92 Million |
Research and Development | $14.27 Million |
Net Income/Loss Attributable To Parent | $4.22 Million |
Costs And Expenses | $104.52 Million |
Net Income/Loss Available To Common Stockholders, Basic | $4.22 Million |
Basic Earnings Per Share | $0.13 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Income/Loss From Continuing Operations After Tax | $4.22 Million |
Income Tax Expense/Benefit, Current | $29000.00 |
Operating Income/Loss | $3.92 Million |
Benefits Costs and Expenses | $104.52 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Income/Loss From Continuing Operations Before Tax | $4.25 Million |
Operating Expenses | $56.92 Million |
Income Tax Expense/Benefit | $29000.00 |
Selling, General, and Administrative Expenses | $42.66 Million |
Diluted Average Shares | $35.68 Million |
Net Income/Loss | $4.22 Million |
Diluted Earnings Per Share | $0.12 |
Gross Profit | $60.84 Million |
Basic Average Shares | $33.44 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Balance Sheet
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Liabilities | $575.65 Million |
Noncurrent Assets | $293.10 Million |
Noncurrent Liabilities | $515.60 Million |
Accounts Payable | $13.13 Million |
Equity | $209.92 Million |
Equity Attributable To Noncontrolling Interest | $0.00 |
Other Current Assets | $440.32 Million |
Current Assets | $492.48 Million |
Fixed Assets | $271.74 Million |
Current Liabilities | $60.05 Million |
Other Non-current Assets | $19.16 Million |
Other Current Liabilities | $26.15 Million |
Intangible Assets | $2.20 Million |
Equity Attributable To Parent | $209.92 Million |
Wages | $20.77 Million |
Liabilities And Equity | $785.57 Million |
Assets | $785.57 Million |
Inventory | $52.15 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.